This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Short Rib Syndrome [Asphyxiating Thoracic Dystrophy]짧은늑골증후군 (단늑골증후군)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q77.2 (Short rib syndrome) | Special Copayment Reduction: V228 (ultra-rare disease)
B. SynonymsAsphyxiating thoracic dysplasia [Jeune syndrome], Short rib syndrome, Jeune syndrome, Asphyxiating Thoracic Dystrophy (ATD), Jeune asphyxiating thoracic dystrophy (JATD), related to Short rib-polydactyly syndrome
C. Adult onsetVery low likelihood of first presenting in adulthood — respiratory failure immediately after birth is the main initial clinical problem, and many die in infancy. Some mild phenotypes survive through childhood and adolescence, and cases surviving to adulthood exist, but ongoing management of renal, hepatic, and retinal complications is required.
1. History1955: first described by Jeune et al. → 1970s–90s: expansion of the clinical spectrum → 2009: IFT80 gene identified → 2013: multiple cilia-related genes including DYNC2H1 and WDR19 identified → currently more than 20 causative genes identified.
2. CausesCiliopathy. Variants in genes related to intraflagellar transport, such as IFT80, DYNC2H1, WDR19, TTC21B, IFT140, and NEK1. Autosomal recessive. Ciliary dysfunction → impaired chondrocyte differentiation signaling (Hedgehog pathway).
3. GeneticsAutosomal recessive. More than 20 causative genes (IFT80, DYNC2H1, WDR34, WDR35, IFT140, TTC21B, NEK1, TCTEX1D2, etc.). DYNC2H1 is the most common (30–40%). High genetic heterogeneity. Recurrence risk 25%.
4. General epidemiologyAbout 1 in 100,000–130,000 births. No sex predilection. Occurs in all ethnic groups worldwide, including Korea. More frequent in populations with high rates of consanguineous marriage. Very few registered under Special Copayment Reduction code V228 in Korea.
5. PathophysiologyDefective intraflagellar transport (IFT) function of the primary cilium → abnormal Hedgehog (Hh) signaling pathway → impaired chondrocyte proliferation and differentiation → shortened ribs and narrowed thorax → restricted lung development. At the same time, dysfunction of renal tubular cilia → renal cysts (nephronophthisis-like).
6. SymptomsNeonates: narrow, short thorax, respiratory failure (risk of asphyxiation). Moderate limb shortening, short ribs, polydactyly (feet or hands, in some). Kidney: decreased renal function → chronic renal failure. Liver: hepatic fibrosis, bile duct proliferation. Retina: retinitis pigmentosa. Oral: dental abnormalities.
7. SignsX-ray: short horizontal ribs (bell-shaped thorax), limb shortening, mild metaphyseal abnormalities. Pelvis: trident acetabulum. Renal ultrasound: hyperechoic kidneys. Fundus examination: pigmentary abnormalities. Decreased pulmonary function, oxygen dependence.
8. ScreeningPrenatal ultrasound: shortened ribs, narrow chest circumference, moderate limb shortening (milder than lethal dysplasia). If there is a family history, analysis of a related gene panel after CVS or amniocentesis. Cannot be detected by NIPT (single-gene disease).
9. DiagnosisPrenatal ultrasound + molecular genetics (ciliopathy panel NGS or WES). Neonates: whole-body skeletal radiographs, renal and liver ultrasound, fundus examination. Renal biopsy (if needed). Genetic confirmation is essential.
10. TreatmentThoracic expansion surgery (lateral thoracic expansion, LTE): promotion of lung growth by VEPTR device insertion or sternotomy thoracic expansion. Respiratory support (oxygen, CPAP, mechanical ventilation). Renal replacement therapy (dialysis, kidney transplantation). Liver transplantation. Retinal monitoring. Nutritional support.
11. PrognosisInfant mortality approximately 50–70% (respiratory failure). Survival improved by thoracic expansion surgery. In survivors, respiratory function may improve through natural expansion of the thorax with growth. Major organ complications (renal failure, liver failure, retinal degeneration) determine long-term prognosis.
12. PreventionGenetic counseling (recurrence risk 25%). If there is a family history, prenatal diagnosis by PGT-M or CVS/amniocentesis. After confirmation, form a multidisciplinary perinatal management team. Establish an early respiratory management plan.
13. ReferencesJeune M et al. 1955 Arch Fr Pediatr; Beales PL et al. 2007 Am J Hum Genet; Schmidts M et al. 2013 Am J Hum Genet … and 7 others

1. History

Short rib syndrome [asphyxiating thoracic dystrophy (ATD)] was first reported in 1955 when the French pediatrician Mathis Jeune and colleagues described two siblings who died early after birth with a narrow thorax and respiratory failure. Jeune described the features of this disease: a narrow, bell-shaped thorax, shortened ribs, and mild limb shortening. The disease later became widely known as 'Jeune syndrome' or 'asphyxiating thoracic dystrophy (ATD)'.

As similar cases were reported around the world in the 1970s and 1980s, the clinical spectrum expanded. In particular, beyond the typical phenotype with thoracic narrowing alone, cases accompanied by polydactyly, renal cysts, retinal degeneration, and hepatic fibrosis accumulated, and it came to be recognized that this disease is not a simple thoracic malformation but a systemic disease involving multiple organs. These observations became the basis for predicting that this disease belongs to the category of ciliopathy.

Molecular genetic understanding advanced rapidly from the mid-2000s. In 2009, the group of Beales identified the IFT80 gene, which encodes a component protein of intraflagellar transport (IFT), as the first causative gene of Jeune syndrome. Subsequently, between 2013 and 2016, multiple additional genes involved in retrograde IFT, including DYNC2H1, WDR19, IFT140, TTC21B, WDR34, WDR35, NEK1, and TCTEX1D2, were identified. This established Jeune syndrome as a genetically highly heterogeneous ciliopathy.

In terms of treatment, Cambino and Campbell et al. began reporting the effect of thoracic expansion surgery in 1989, and with the introduction of lateral thoracic expansion using the VEPTR (vertical expandable prosthetic titanium rib), a spinal assist device, in 2004, survival and quality of life of patients with Jeune syndrome began to improve. In Korea as well, experience with the VEPTR procedure is accumulating at a small number of specialized centers, and the importance of a multidisciplinary approach is emphasized.


2. Causes

Short rib syndrome [Jeune syndrome] is a type of ciliopathy caused by pathogenic variants in genes involved in the intraflagellar transport (IFT) function of the primary cilium. The primary cilium is a non-motile antenna-like structure present on the surface of mammalian cells and is a key relay pathway for various developmental signals, including Hedgehog (Hh) signaling, PDGF receptor signaling, and determination of cell polarity.

IFT (intraflagellar transport) mechanism and related genes: Intraflagellar transport consists of an anterograde pathway (IFT-B complex, kinesin-2 motor), which transports cargo (cargo proteins) along the axoneme of the cilium from the ciliary base to the tip, and a retrograde pathway (IFT-A complex, dynein-2 motor), which transports from the tip to the base. In Jeune syndrome, variants in genes involved in retrograde IFT are found more commonly.

Major causative genes: DYNC2H1 (dynein cytoplasmic 2 heavy chain 1, 7p21.1) is the most common causative gene, with variants identified in about 30–40% of all patients with Jeune syndrome. This gene encodes the heavy chain of cytoplasmic dynein 2, the motor protein of retrograde IFT. In addition, more than 20 genes, including IFT80 (3q25.33), WDR19 (4p14), IFT140 (16p13.3), TTC21B (2q24.3), WDR34 (9q34.11), WDR35 (2p24.1), NEK1 (4q33), and TCTEX1D2 (3q21.3-q21.33), have been reported to date.

Mode of inheritance: All known causative genes are inherited in an autosomal recessive manner. Therefore, when both parents are carriers, there is a 25% recurrence risk in children. Compound heterozygous variants — that is, inheriting two different variants of the same gene, one from each parent — are more frequent than homozygous variants. Even with the same variant or gene, the phenotype may differ depending on genetic background and environmental factors (phenotypic variability).

Common pathway of molecular pathology: Whichever gene is mutated, IFT function of the primary cilium is ultimately impaired and Hedgehog (Hh) signaling becomes abnormal. Hedgehog signaling is essential for chondrocyte differentiation, growth plate regulation, lung branching morphogenesis, renal tubule development, retinal photoreceptor function, and hepatobiliary development. Therefore, impaired ciliary function gives rise to a multi-organ syndrome affecting all of these organs simultaneously.


3. Genetics

Jeune syndrome is a genetically highly heterogeneous autosomal recessive ciliopathy. More than 20 causative genes have been identified to date, with a complex pattern of inheritance in which variants in different genes are observed in the same phenotype.

DYNC2H1 gene (7p21.1): The most common causative gene, accounting for about 30–40% of all Jeune syndrome. DYNC2H1 encodes the heavy chain of the cytoplasmic dynein 2 complex responsible for retrograde IFT. Various types of variants, including missense, nonsense, frameshift, and splice-site, have been reported in this gene. Notably, in patients with DYNC2H1 variants, compound heterozygosity with a missense variant on one allele and a loss-of-function variant on the other is common, while homozygosity for loss-of-function variants is lethal or markedly worsens the phenotype.

IFT-B complex genes: Variants in anterograde IFT-B complex genes such as IFT80, IFT52, and IFT172 also cause Jeune syndrome, but are relatively rarer than variants in IFT-A and dynein-2 complex genes. Patients with IFT-B gene variants often show a more severe phenotype.

Genotype-phenotype correlation: The genotype-phenotype correlation in Jeune syndrome is complex. Even between siblings with the same DYNC2H1 variants, the degree of thoracic narrowing and the presence of renal or retinal involvement may differ. This suggests that genetic background (modifier genes) and environmental factors influence the phenotype. In general, homozygosity for loss-of-function variants (nonsense, frameshift) is associated with a more severe phenotype than compound heterozygosity for missense variants.

Overlap with the ciliopathy spectrum: Jeune syndrome sometimes shares causative genes with other ciliopathies. For example, IFT140 variants are associated with Sensenbrenner syndrome (cranioectodermal dysplasia) in addition to Jeune syndrome. WDR19 variants show a phenotype overlapping with short-rib polydactyly syndrome. NEK1 variants have also been reported to be associated with some cases of amyotrophic lateral sclerosis (ALS). This gene-phenotype complexity is why a broad panel or WES is needed in the diagnosis of ciliopathies.

Prenatal diagnosis and PGT: Because of autosomal recessive inheritance with a 25% recurrence risk, when molecular confirmation (identification of the causative gene and variants) has been made in a previously affected child, prenatal diagnosis is possible in the next pregnancy by targeted variant analysis after chorionic villus sampling (CVS) or amniocentesis. Preimplantation genetic testing (PGT-M) is performed at some centers as a method of excluding affected embryos in combination with in vitro fertilization.


4. General epidemiology

Jeune syndrome [short rib syndrome] is a rare skeletal ciliopathy reported to occur at a frequency of about 1 in 100,000–130,000 births. However, determining the exact incidence is difficult owing to intrauterine death, infant death, and missed diagnosis of mild cases.

Sex and ethnicity: Because of autosomal recessive inheritance, there is no difference in occurrence by sex. There is no evidence of higher incidence in a particular ethnic group, but in populations with a high rate of consanguinity (some Middle Eastern, South Asian, and North African populations), the frequency of homozygous variants is high and the incidence may be relatively higher. Founder mutations have been reported but are not limited to a specific ethnic group.

Status in Korea: In Korea it is registered under Special Copayment Reduction code V228 (ultra-rare disease), and the number of registered patients is extremely small. Diagnosis is mainly made by clinical suspicion from the combination of neonatal respiratory failure after birth and characteristic radiographic findings, followed by molecular genetic confirmation. A multidisciplinary approach is provided by pediatric thoracic surgery, pediatrics, and medical genetics departments at major domestic children's hospitals, but concentration of experience and infrastructure is needed. Support is available through the Korea Foundation for Rare Diseases and the Korea Disease Control and Prevention Agency (KDCA) rare disease registry program.

Epidemiological particularities: Jeune syndrome has a broad clinical spectrum, ranging from severe cases that die of immediate respiratory failure in the neonatal period to mild cases that survive to adulthood with relatively mild thoracic narrowing. Because of this phenotypic diversity, mild cases are sometimes diagnosed in childhood or adolescence from clues such as recurrent respiratory infections, renal abnormalities, and retinal degeneration. Therefore, the actual incidence may be higher than reported.

Mortality statistics: In the past (before thoracic expansion surgery), neonatal mortality reached 60–70%. Survival has improved since the introduction of thoracic expansion surgery (VEPTR and other methods), but infant death is still common. In surviving patients, chronic renal failure and hepatic complications are the main factors determining long-term prognosis.


5. Pathophysiology

The pathophysiology of Jeune syndrome centers on defective retrograde intraflagellar transport (retrograde IFT) function of the primary cilium and the resulting impairment of Hedgehog (Hh) signaling.

Normal function of the primary cilium and IFT: The primary cilium is a single non-motile cellular projection originating from the basal body, and functions as a signal-receiving organelle in various cells, including growth plate chondrocytes, renal tubular epithelial cells, retinal photoreceptor outer segments, and hepatobiliary epithelial cells. Intraflagellar transport (IFT) carries the proteins needed for the growth, maintenance, and signal transduction of the cilium through the cooperation of IFT complexes (IFT-A, IFT-B), composed of hundreds of proteins, and molecular motors (anterograde: kinesin-2; retrograde: dynein-2).

Retrograde IFT defects and abnormal ciliary structure: With variants in retrograde IFT-related genes such as DYNC2H1, WDR34, and WDR35, transport from the ciliary tip to the base is blocked. As a result, IFT cargo proteins accumulate at the ciliary tip, and the cilium abnormally swells or shortens. Signaling molecules (especially Hh receptors and effectors) that should return from the base to the cytoplasm become trapped in the cilium.

Impaired Hedgehog signaling → abnormal chondrocyte differentiation: Normally, when Sonic Hedgehog (SHH) binds its receptor Patched (PTCH1), Smoothened (SMO) moves into the cilium, the active form of the transcription factors GLI2/3 is generated, and it activates chondrocyte proliferation and differentiation genes. With defective IFT function, movement of SMO into the cilium is impeded and GLI transcription factor processing becomes abnormal, inhibiting proliferation and hypertrophy of growth plate chondrocytes. As a result, endochondral ossification of the ribs and long bones is insufficient, and a narrow thorax with short, horizontally arranged ribs is formed.

Renal ciliary dysfunction → renal cysts and renal failure: The primary cilia of renal tubular epithelial cells are essential for sensing fluid flow and maintaining tubular structure. With defective IFT function, the planar cell polarity of renal tubular cells is damaged, and the tubules dilate and become cystic (pathology resembling nephronophthisis). This leads to proteinuria, decreased renal function, and hypertension, and may progress in the long term to end-stage renal disease (ESRD).

Ciliary dysfunction in other organs: The outer segment of retinal photoreceptors is a modified ciliary structure, and with defective IFT function, transport of visual signal proteins to the outer segment is impaired, producing degeneration resembling retinitis pigmentosa. Ciliary dysfunction of the hepatobiliary epithelium causes impaired bile flow, hepatic fibrosis, and bile duct proliferation (ductal plate malformation). Because cilia are also involved in enamel formation during oral development, dental abnormalities appear in some patients.


6. Symptoms

The clinical symptoms of Jeune syndrome are dominated by thoracic and respiratory symptoms, accompanied by multi-organ symptoms involving the kidney, liver, retina, and others. The severity of symptoms varies widely from patient to patient.

Thoracic and respiratory symptoms — the key clinical problem: A narrow, short thorax (bell-shaped thorax) is observed at birth or in the neonatal period. Thoracic narrowing restricts lung development, causing pulmonary hypoplasia, which presents immediately after birth as respiratory failure, cyanosis, tachypnea, intercostal retractions, and nasal flaring. Severe cases require endotracheal intubation and mechanical ventilation. Even in mild cases, recurrent respiratory infections (pneumonia, bronchitis) are common, and chronic respiratory failure due to reduced lung volume may progress. If the infant survives, the thorax tends to expand to some extent naturally with growth and respiratory function improves, but thoracic expansion surgery (VEPTR) actively promotes this process.

Limb and skeletal symptoms: Limb shortening is milder than in lethal skeletal dysplasia or achondrogenesis and is characterized by moderate rhizomelic brachymelia. Polydactyly of the fingers and toes (mainly postaxial) is accompanied in about 20–30%. Abnormalities of the limb epiphyses and mild irregularity of the growth plates may be seen on radiographs.

Renal symptoms: Renal involvement appears at various times and can manifest from the neonatal period to adulthood. Proteinuria, decreased renal function (elevated creatinine), renal cysts, and nephrocalcinosis occur. Decreased renal function beginning in infancy or childhood sometimes progresses gradually to end-stage renal disease (ESRD), in which case dialysis or kidney transplantation is required.

Hepatic symptoms: Hepatic fibrosis, bile duct proliferation, and hepatomegaly may occur. In severe cases, variceal bleeding, ascites, and liver failure due to portal hypertension occur, and liver transplantation is required. Elevated liver enzymes (AST, ALT, GGT) are seen on blood tests.

Retinal symptoms: Retinal degeneration resembling retinitis pigmentosa occurs and may progress to night vision loss, visual field constriction, and ultimately blindness. These symptoms mainly appear after childhood.


7. Signs

The objective signs of Jeune syndrome are identified through physical examination, radiography, ultrasound, and ophthalmologic examination.

Physical examination signs: A narrow, bell-shaped thorax is the most characteristic. The abdomen protrudes relatively prominently. The limbs are moderately short, and skin folds of the limbs may be present. Polydactyly of the fingers and toes, when present, is easily identified visually. On auscultation, decreased breath sounds, wheezing, and crackles with recurrent infection may be heard. Abdominal palpation reveals hepatomegaly and splenomegaly (in portal hypertension).

Skeletal radiographic signs: On whole-body skeletal radiography (babygram) or chest radiography, the ribs are short and horizontally arranged, giving a 'bell-shaped thorax'. The long bones are moderately shortened, and the metaphyses are slightly irregular. A trident acetabulum of the pelvis (a form in which the acetabular roof is horizontal and the base of the pelvis protrudes sharply) is a characteristic finding of Jeune syndrome. The spine is normal or shows only minor abnormalities.

Renal ultrasound and imaging signs: Renal ultrasound shows increased renal parenchymal echogenicity (hyperechoic kidneys), renal cysts, nephrocalcinosis, and loss of corticomedullary differentiation. Kidney size may be normal, enlarged, or atrophic. Renal MRI is used as an adjunct to assess the distribution of renal cysts and the degree of fibrosis.

Ophthalmologic examination signs: Fundoscopy may show retinal pigment epithelial degeneration, retinal vascular narrowing, and optic disc pallor. Retinal function is evaluated by visual acuity testing, visual field testing, and electroretinography (ERG). A generalized decrease in retinal response on ERG is characteristic.

Pulmonary function test signs: Decreased lung volumes (TLC, FVC), decreased lung compliance, and reduced oxygen saturation are observed. The 6-minute walk test (6MWT) and exercise stress testing show reduced exercise capacity. Chest CT quantitatively evaluates pulmonary hypoplasia, thoracic narrowing, and lung segmental abnormalities.


8. Screening

There is no general population screening program for Jeune syndrome; prenatal ultrasound and family-history-based molecular screening are the main methods.

Prenatal ultrasound: On detailed ultrasound at 18–22 weeks of gestation, thoracic narrowing (abnormal chest/abdominal circumference ratio), rib shortening (short, horizontal arrangement), and moderate limb shortening are the main screening findings. The ultrasound findings of Jeune syndrome are milder than those of thanatophoric dysplasia, so differentiation is important. Accompanying polydactyly is a clue. Polyhydramnios accompanies in some cases. The thoracic circumference/head circumference (TC/HC) ratio and the femur length/abdominal circumference (FL/AC) ratio are useful screening indicators.

3D ultrasound and MRI: 3D ultrasound quantifies thoracic volume and lung volume to predict the risk of respiratory failure after birth. Fetal MRI is used to evaluate lung volume (lung-to-liver signal intensity ratio) and renal structural abnormalities. Using the predicted lung volume, the need for immediate mechanical ventilation after birth can be predicted, and the delivery site and resuscitation team can be prepared.

Family-history-based molecular screening: When a causative gene variant has been identified in a previously affected child, prenatal confirmation is possible in the next pregnancy by targeted variant analysis after CVS (11–14 weeks of gestation) or amniocentesis (15–20 weeks of gestation). When the causative gene has been identified, affected embryos can be excluded at the preimplantation stage through PGT-M. In families in which the causative gene has not been identified, follow-up detailed ultrasound during pregnancy is the only screening method.

Limitations of newborn screening: Jeune syndrome is not included in the national newborn metabolic screening tests. Neonatal clinical features (thoracic narrowing, respiratory failure, radiographic findings) are the starting point of diagnosis. A clinical diagnosis is made from the combination of whole-body skeletal radiography immediately after birth and clinical findings, followed by molecular genetic confirmation.


9. Diagnosis

Definitive diagnosis of Jeune syndrome is made by integrating clinical and radiographic findings with molecular genetic analysis. Because of high genetic heterogeneity, comprehensive panel analysis rather than single-gene analysis is standard.

Clinical and radiographic diagnosis: The combination of neonatal respiratory failure, a narrow bell-shaped thorax, and characteristic skeletal radiographic findings (short horizontal ribs, trident pelvis, mild limb shortening) is the basis of clinical diagnosis. Diagnostic confidence rises when polydactyly, renal abnormalities, and retinal findings accompany. Differentiation is needed from thanatophoric dysplasia, achondrogenesis, short-rib polydactyly syndrome (SRPS), and Ellis-van Creveld syndrome (EVC).

Molecular genetic diagnosis: NGS of a ciliopathy-related gene panel (including more than 20 genes such as IFT80, DYNC2H1, WDR19, IFT140, TTC21B, WDR34, WDR35, NEK1, TCTEX1D2) is recommended as the first-line molecular diagnostic method. If panel analysis is negative, expand to clinical whole-exome sequencing (WES) or whole-genome sequencing (WGS). Analysis of parental variants is needed to confirm carrier status and calculate recurrence risk.

Renal, hepatic, and ophthalmologic evaluation: Renal ultrasound (renal cysts, nephrocalcinosis, abnormal renal parenchymal echogenicity), serum renal function tests (creatinine, BUN, estimated glomerular filtration rate), and urinalysis (proteinuria, red blood cell casts). Liver function tests (AST, ALT, GGT, bilirubin) and abdominal ultrasound (hepatic fibrosis, bile duct dilatation, splenomegaly). Ophthalmologic examination (fundoscopy, ERG, visual field testing) is performed regularly from early after birth.

Pulmonary function and imaging evaluation: Chest X-ray, chest CT (quantification of lung volume and thoracic shape), pulmonary function tests (depending on age). Continuous oxygen saturation monitoring. Echocardiographic evaluation if pulmonary hypertension accompanies.


10. Treatment

Treatment of Jeune syndrome centers on respiratory and thoracic management, with long-term management of multi-organ complications involving the kidney, liver, retina, and others alongside. There is currently no fundamental gene-correcting therapy.

Thoracic expansion surgery — VEPTR (Vertical Expandable Prosthetic Titanium Rib): The core of Jeune syndrome treatment is lateral thoracic expansion. The VEPTR (vertical expandable prosthetic titanium rib) is a technique in which a metal rod is inserted between two ribs to widen the thorax laterally, and the rod is then lengthened (distracting procedure) 2–3 times with growth to provide space for the growing lung. It is generally performed targeting 3–6 months of age and a body weight of 5 kg or more, and is maintained until adolescence after the last lengthening. Other surgical methods such as sternal split thoracic expansion and rib segment expansion are also used. After thoracic expansion surgery, promotion of lung growth and improvement of respiratory function have been reported, and in some patients weaning from oxygen dependence has occurred.

Respiratory support: When endotracheal intubation and mechanical ventilation are needed in the neonatal period, they act as a bridge to buy time for lung development and thoracic expansion surgery. Tracheostomy is considered in patients dependent on long-term mechanical ventilation. Oxygen supplementation, high-flow nasal cannula (HFNC), and CPAP are used for moderate respiratory failure. To prevent recurrent pneumonia, RSV prophylactic injection (palivizumab) and influenza and pneumococcal vaccination are recommended.

Renal management: When renal involvement is confirmed, reduction of proteinuria and renal protection are attempted with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) in consultation with a nephrologist. Blood pressure control, prevention of growth delay, and maintenance of electrolyte balance are important. In end-stage renal disease (ESRD), peritoneal dialysis or hemodialysis is performed, followed by renal transplantation.

Hepatic management: When hepatic complications are confirmed, a pediatric gastroenterologist takes part in liver function monitoring and management of portal hypertension complications (endoscopic variceal ligation, beta-blockers). When progressing to liver failure, liver transplantation is the only fundamental treatment.

Retinal and ophthalmologic management: Regular follow-up by an ophthalmologist (1–2 times a year) is needed from the start of diagnosis. There is currently no specific treatment for retinal degeneration associated with Jeune syndrome, but wearing UV-blocking glasses, low-vision rehabilitation, and use of visual aids are helpful.


11. Prognosis

The prognosis of Jeune syndrome differs greatly depending on the severity of thoracic narrowing, the timing and effect of thoracic expansion surgery, and the presence of renal and hepatic involvement.

Short-term prognosis (infancy): Respiratory failure is the most immediate life-threatening factor. In the past (before surgery), infant mortality reached 60–70%, but survival has improved since the introduction of thoracic expansion surgery (VEPTR, etc.). Survival is significantly improved in patients who underwent thoracic expansion surgery, and when thoracic growth is promoted by repeated lengthening surgeries, lung development may become sufficient around 2–5 years of age and weaning from oxygen dependence may occur.

Long-term prognosis (childhood to adulthood): In patients who survive respiratory failure, the main factors determining long-term prognosis are renal and hepatic complications. When chronic renal failure progresses, dialysis or kidney transplantation is needed, and renal function improves after transplantation. Retinal degeneration progresses gradually and can lead to visual loss and ultimately blindness. Skeletal growth often improves with growth to the extent that limb shortening does not greatly interfere with daily life. Intellectual development and neurological function are generally normal, which is an important prognostic difference from lethal skeletal dysplasia.

Quality of life: In surviving patients, quality of life is limited by repeated surgeries (VEPTR lengthening), oxygen use, recurrent respiratory infections, and management of renal complications. However, preservation of intellectual and neurological function opens the possibility for patients to take part in education, social activities, and work. Long-term support from a multidisciplinary team and education of patients and families are important for improving quality of life.


12. Prevention

Because Jeune syndrome is inherited in an autosomal recessive manner, it is passed from carrier parents to children with a 25% probability. A systematic prevention strategy is possible when there is a family history.

Genetic counseling: When Jeune syndrome is diagnosed, consultation with a medical geneticist and genetic counselor is essential. The carrier status of both parents is confirmed by molecular genetic testing, and the recurrence risk in future pregnancies (25%) and the options (natural pregnancy + prenatal diagnosis, PGT-M, adoption, etc.) are explained. Carrier testing of extended family members (siblings, etc.) is also recommended.

Preimplantation genetic testing (PGT-M): When the causative gene variant has been identified, PGT-M can exclude affected embryos and implant unaffected embryos. However, because there are more than 20 heterogeneous IFT-related genes, the causative gene and variants must be molecularly confirmed before designing PGT-M.

Prenatal diagnosis: In the next pregnancy of carrier parents, affected status is confirmed by targeted variant analysis after CVS (11–14 weeks of gestation) or amniocentesis (15–20 weeks of gestation). In families in which the causative gene has not been identified, detailed ultrasound (12–22 weeks of gestation, at 2–4-week intervals) detects findings of thoracic narrowing, rib shortening, and limb shortening early.

Advance formation of a multidisciplinary perinatal management team: After prenatal diagnosis, a multidisciplinary team composed of specialists in thoracic surgery, pediatrics, pediatric intensive care, nephrology, ophthalmology, and genetics, together with a social worker and psychology specialist, is organized in advance to prepare for immediate integrated management right after birth. Such advance planning contributes greatly to optimizing the timing of early VEPTR surgery and to family support.


13. References

  1. Jeune M, Carron R, Beraud C, Loaec Y. Polychondrodystrophie avec blocage thoracique d'évolution fatale. Arch Fr Pediatr. 1955;12(9):886-891. PMID: 13267920.

  2. Beales PL, Bland E, Tobin JL, et al. IFT80, which encodes a conserved intraflagellar transport protein, is mutated in Jeune asphyxiating thoracic dystrophy. Nat Genet. 2007;39(6):727-729. DOI: 10.1038/ng2038. PMID: 17468754.

  3. Schmidts M, Arts HH, Bongers EM, et al. Exome sequencing identifies DYNC2H1 mutations as a common cause of asphyxiating thoracic dystrophy (Jeune syndrome) without major polydactyly, renal or retinal involvement. J Med Genet. 2013;50(5):309-323. DOI: 10.1136/jmedgenet-2012-101284. PMID: 23456818.

  4. Baujat G, Huber C, El Hokayem J, et al. Asphyxiating thoracic dysplasia: clinical and molecular review of 39 families. J Med Genet. 2013;50(2):91-98. DOI: 10.1136/jmedgenet-2012-101282. PMID: 23275527.

  5. Campbell RM Jr. Congenital scoliosis and thoracic insufficiency syndrome (TIS). Spine (Phila Pa 1976). 2009;34(17 Suppl):S52-60. DOI: 10.1097/BRS.0b013e3181ab8f8b. PMID: 19622949.

  6. Tamburrini G, Aversano M, Silvestri E, et al. Jeune's syndrome: report of a case with long survival. Pediatr Neurosurg. 2004;40(1):51-53. DOI: 10.1159/000076729. PMID: 14976427.

  7. Huber C, Cormier-Daire V. Ciliary disorder of the skeleton. Am J Med Genet C Semin Med Genet. 2012;160C(3):165-174. DOI: 10.1002/ajmg.c.31336. PMID: 22791528.

  8. Unger S, Ferreira CR, Mortier GR, et al. Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet A. 2023;191(5):1164-1209. DOI: 10.1002/ajmg.a.63132. PMID: 36779427.

  9. Davis SD, Fordham LA, Bhatt U, et al. Longitudinal pulmonary function tests and CT assessment of the chest after vertical expandable prosthetic titanium rib (VEPTR). Pediatr Radiol. 2014;44(3):314-322. DOI: 10.1007/s00247-013-2827-0. PMID: 24326890.

  10. Halbritter J, Bizet AA, Schmidts M, et al. Defects in the IFT-B component IFT172 cause Jeune and Mainzer-Saldino syndromes in humans. Am J Hum Genet. 2013;93(5):915-925. DOI: 10.1016/j.ajhg.2013.09.012. PMID: 24140113.